Retatrutide is an investigational synthetic peptide belonging to the triple-receptor agonist class. It is characterised by activity at three metabolic receptors: GLP-1, GIP and glucagon.

LIFE supplies Retatrutide 10 mg as a high-purity, lyophilised peptide for laboratory and analytical research. Each batch is accompanied by a Certificate of Analysis (COA), with additional independent verification available for selected batches.

Product characteristics

Specification	Details
Product	Retatrutide
Quantity	10 mg per vial
Form	Lyophilised powder
Purity	≥99% (HPLC)
Molecular formula:	C₂₂₁H₃₄₂N₄₆O₆₈
Molecular weight	4731.33 g/mol
Research category	Triple GLP-1/GIP/glucagon receptor agonist
Storage	Refrigerated at 2–8°C
Intended application	Laboratory and analytical research

Quality control

Current batch: RT10-260410

Internal HPLC purity: 99.17%
Independent verification: 99.57%
Testing laboratory: Janoshik Analytical

View third-party verification.

View Certificate of Analysis.

Further information

For a comparison of related compounds and their receptor profiles, see our Retatrutide vs Tirzepatide research comparison.

For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

GLP-1/GIP/glucagon agonist

Retatrutide 10 mg